Q-Med Board Endorses Galderma's Sweetened Bid
Q-Med AB's board of directors is urging reluctant shareholders to accept Galderma Pharma SA's latest takeover bid, which the skin care company has boosted from $978 million to $1.2 billion in...To view the full article, register now.
Already a subscriber? Click here to view full article